Revenue growth is highly volatile due to IFRS 17, with a -52.1% YoY decline in 2026Q2, yet underwriting profitability improved to a combined ratio of 85.9% from 96.4% in 2024Q1, indicating stronger core margins.
Manulife Financial Corporation (MFC) annual income statement — 28-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 |
|---|
| Revenue | 57.93B | 53.01B | -7.29B | -7.04B | 24.16B | 59.84B | 77.12B | 77.82B | 37.26B | 56.65B | 51.69B | 32.81B | 53.07B | 17.48B | 28.08B | 49.98B | 37.62B | 40.11B | 33B | 35.58B | 34.19B | 32.69B | 26.97B | 16.51B | 16.53B | 16.23B | 14.15B | 14.11B | 10.53B |
| Revenue Growth % | -15.99% | 827.41% | -3.57% | -129.13% | -59.63% | -22.41% | -0.9% | 108.84% | -34.22% | 9.59% | 57.52% | -38.17% | 203.51% | -37.72% | -43.83% | 32.87% | -6.21% | 21.53% | -7.25% | 4.06% | 4.6% | 21.22% | 63.38% | -0.16% | 1.85% | 14.69% | 0.31% | 34% | - |
| Medical Costs & Claims | 30.82B | 39.49B | -20.92B | -17.72B | 22.52B | 41.2B | 59.87B | 60.76B | 20.3B | 44.33B | 38.84B | 21.41B | 41.57B | 6.66B | 20.61B | 42.82B | 27.59B | 30.08B | 22.2B | 24.19B | 16.67B | 17.12B | 18.87B | 9.26B | 9.99B | 9.8B | 7.3B | 888.21M | 752.15M |
| Medical Cost Ratio % | 53.21% | 74.49% | 287.02% | 251.8% | 93.2% | 68.86% | 77.63% | 78.08% | 54.47% | 78.26% | 75.14% | 65.25% | 78.33% | 38.1% | 73.41% | 85.67% | 73.33% | 75% | 67.27% | 68% | 48.76% | 52.36% | 69.97% | 56.11% | 60.41% | 60.38% | 51.6% | 6.3% | 7.14% |
| Gross Profit | 27.11B | 13.53B | 13.63B | 10.68B | 1.64B | 18.64B | 17.25B | 17.06B | 16.97B | 12.32B | 12.85B | 11.4B | 11.5B | 10.82B | 7.46B | 7.16B | 10.03B | 10.03B | 10.8B | 11.39B | 17.52B | 15.57B | 8.1B | 7.25B | 6.55B | 6.43B | 6.85B | 13.22B | 9.78B |
| Gross Margin % | 46.79% | 25.51% | -187.02% | -151.8% | 6.8% | 31.14% | 22.37% | 21.92% | 45.53% | 21.74% | 24.86% | 34.75% | 21.67% | 61.9% | 26.59% | 14.33% | 26.67% | 25% | 32.73% | 32% | 51.24% | 47.64% | 30.03% | 43.89% | 39.59% | 39.62% | 48.4% | 93.7% | 92.86% |
| Gross Profit Growth % | - | -0.77% | 27.6% | 549.76% | -91.18% | 8.01% | 1.14% | 0.55% | 37.73% | -4.14% | 12.68% | -0.84% | 6.25% | 45% | 4.25% | -28.61% | 0.05% | -7.18% | -5.13% | -35.01% | 12.52% | 92.32% | 11.76% | 10.69% | 1.79% | -6.12% | -48.19% | 35.23% | - |
| Operating Expenses | 18.73B | 6.43B | 6.54B | 4.23B | 4.78B | 10.51B | 10.48B | 10.84B | 11.45B | 9.82B | 9.52B | 8.79B | 7.24B | 7.08B | 6.22B | 7.01B | 12.36B | 10.18B | 10.22B | 5.78B | 12.19B | 11.25B | 4.67B | 5.4B | 4.87B | 5.07B | 5.51B | 179.96M | 156.82M |
| OpEx / Revenue % | 32.33% | 12.13% | -89.74% | -60.11% | 19.79% | 17.56% | 13.59% | 13.93% | 30.72% | 17.33% | 18.42% | 26.77% | 13.64% | 40.47% | 22.16% | 14.03% | 32.85% | 25.38% | 30.98% | 16.25% | 35.64% | 34.42% | 17.33% | 32.72% | 29.47% | 31.22% | 38.92% | 1.28% | 1.49% |
| Depreciation & Amortization | -605.54M | 876.28M | -1.51B | 581M | -1.47B | 529M | 656M | 626M | 747M | 560M | 693M | 580M | 462M | 426M | 390M | 345M | 316M | 304M | 253M | 281M | 234M | -749M | -608M | -431.61M | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | 85.54% | 86.62% | 197.28% | 191.69% | 112.99% | 86.42% | 91.22% | 92.01% | 85.19% | 95.59% | 93.56% | 92.02% | 91.97% | 78.57% | 95.57% | 99.7% | 106.18% | 100.38% | 98.25% | 84.24% | 84.39% | 86.78% | 87.3% | 88.82% | 89.87% | 91.6% | 90.52% | 7.57% | 8.63% |
| Operating Income | 8.38B | 7.09B | 7.09B | 6.45B | -3.14B | 8.13B | 6.77B | 6.22B | 5.52B | 2.5B | 3.33B | 2.62B | 4.26B | 3.75B | 1.24B | 148M | -2.33B | -152M | 577M | 5.61B | 5.34B | 4.32B | 3.42B | 1.84B | 1.67B | 1.36B | 1.34B | 13.04B | 9.62B |
| Operating Margin % | 14.46% | 13.38% | -97.28% | -91.69% | -12.99% | 13.58% | 8.78% | 7.99% | 14.81% | 4.41% | 6.44% | 7.98% | 8.03% | 21.43% | 4.43% | 0.3% | -6.18% | -0.38% | 1.75% | 15.76% | 15.61% | 13.22% | 12.7% | 11.18% | 10.13% | 8.4% | 9.48% | 92.43% | 91.37% |
| Operating Income Growth % | - | 0.06% | 9.89% | 305.61% | -138.62% | 20% | 8.86% | 12.7% | 120.67% | -24.87% | 27.16% | -38.6% | 13.8% | 201.45% | 739.86% | 106.37% | -1429.61% | -126.34% | -89.71% | 5.06% | 23.46% | 26.19% | 85.64% | 10.22% | 22.82% | 1.64% | -89.72% | 35.56% | - |
| EBITDA | 7.77B | 7.97B | 5.58B | 7.03B | -4.61B | 8.65B | 7.43B | 6.85B | 6.27B | 3.06B | 4.02B | 3.2B | 4.73B | 4.17B | 1.63B | 493M | -2.01B | 152M | 830M | 5.89B | 5.57B | 3.57B | 2.82B | 1.41B | 1.92B | 1.62B | 1.53B | 179.96M | 156.82M |
| EBITDA Margin % | 13.41% | 15.03% | -76.61% | -99.94% | -19.09% | 14.46% | 9.63% | 8.8% | 16.82% | 5.4% | 7.78% | 9.75% | 8.91% | 23.87% | 5.82% | 0.99% | -5.34% | 0.38% | 2.51% | 16.55% | 16.29% | 10.93% | 10.45% | 8.56% | 11.6% | 9.98% | 10.83% | 1.28% | 1.49% |
| Interest Expense | 1.57B | 1.53B | 1.68B | 1.55B | 1.04B | 1.02B | 1.18B | 1.35B | 1.27B | 1.16B | 1.02B | 1.1B | 1.08B | 992.19M | 936.14M | 1.25B | 1.08B | 1.3B | 1.04B | 1.03B | 961.34M | 786.23M | 633.87M | 385M | 243M | 257M | 191M | 179.96M | 156.82M |
| Non-Operating Income | -1.57B | -1.53B | -1.68B | -1.55B | -1.05B | -1.01B | -1.18B | -1.32B | -1.27B | -1.14B | -1.01B | -1.1B | -1.13B | -1.04B | -934M | -1.25B | -1.04B | -1.3B | -1.19B | -1.03B | -932M | -788M | -629M | -385M | -243M | -257M | -191M | 12.86B | 9.46B |
| Pretax Income | 8.38B | 7.09B | 7.09B | 6.45B | -3.14B | 8.13B | 6.77B | 6.22B | 5.52B | 2.5B | 3.33B | 2.62B | 4.26B | 3.75B | 1.24B | 148M | -2.33B | -152M | 577M | 5.61B | 5.34B | 4.32B | 3.42B | 1.84B | 1.67B | 1.36B | 1.34B | 1.17B | 943.68M |
| Pretax Margin % | 14.46% | 13.38% | -97.28% | -91.69% | -12.99% | 13.58% | 8.78% | 7.99% | 14.81% | 4.41% | 6.44% | 7.98% | 8.03% | 21.43% | 4.43% | 0.3% | -6.18% | -0.38% | 1.75% | 15.76% | 15.61% | 13.22% | 12.7% | 11.18% | 10.13% | 8.4% | 9.48% | 8.31% | 8.96% |
| Income Tax | 1.3B | 1.03B | 1.21B | 845M | -1.16B | 1.21B | 1.2B | 718M | 632M | 239M | 196M | 328M | 671M | 581M | -492M | -97M | -799M | -1.57B | 80M | 1.38B | 1.37B | 1.03B | 874M | 316M | 304M | 196M | 273M | 303.33M | 239.15M |
| Effective Tax Rate % | 15.58% | 14.58% | 17.09% | 13.1% | 36.93% | 14.93% | 17.65% | 11.54% | 11.45% | 9.56% | 5.89% | 12.53% | 15.74% | 15.51% | -39.58% | -65.54% | 34.37% | 1034.21% | 13.86% | 24.56% | 25.6% | 23.85% | 25.52% | 17.13% | 18.16% | 14.38% | 20.36% | 25.87% | 25.34% |
| Net Income | 6.73B | 5.78B | 5.63B | 5.46B | -2.1B | 6.66B | 5.33B | 5.27B | 4.67B | 2.07B | 2.99B | 2.22B | 3.52B | 3.12B | 1.71B | 218M | -1.66B | 1.4B | 517M | 4.3B | 3.97B | 3.29B | 2.55B | 1.53B | 1.37B | 1.17B | 1.07B | 869.35M | 704.54M |
| Net Margin % | 11.61% | 10.91% | -77.26% | -77.63% | -8.69% | 11.12% | 6.91% | 6.77% | 12.54% | 3.65% | 5.78% | 6.77% | 6.64% | 17.83% | 6.08% | 0.44% | -4.42% | 3.5% | 1.57% | 12.09% | 11.61% | 10.07% | 9.46% | 9.26% | 8.29% | 7.19% | 7.55% | 6.16% | 6.69% |
| Net Income Growth % | 11.17% | 2.68% | 3.08% | 360.14% | -131.55% | 24.99% | 1.08% | 12.75% | 125.97% | -30.84% | 34.62% | -36.94% | 12.96% | 82.66% | 683.03% | 113.11% | -218.62% | 171.18% | -87.98% | 8.36% | 20.63% | 29.01% | 66.84% | 11.61% | 17.39% | 9.27% | 22.85% | 23.39% | - |
| EPS (Diluted) | 4.03 | 3.07 | 2.84 | 2.61 | -1.10 | 3.54 | 2.93 | 2.77 | 2.35 | 0.98 | 1.41 | 1.05 | 1.80 | 1.62 | 0.88 | 0.02 | -0.22 | 0.82 | 0.32 | 2.78 | 2.51 | 2.03 | 1.81 | 1.66 | 1.44 | 1.19 | 1.11 | 0.88 | 0.73 |
| EPS Growth % | 19.09% | 8.1% | 8.81% | 337.27% | -131.07% | 20.82% | 5.78% | 17.87% | 139.8% | -30.5% | 34.29% | -41.67% | 11.11% | 84.09% | 4300% | 109.09% | -126.83% | 156.25% | -88.49% | 10.76% | 23.65% | 12.15% | 9.04% | 15.28% | 21.01% | 7.21% | 26.14% | 20.55% | - |
| EPS (Basic) | - | 3.08 | 2.85 | 2.62 | -1.10 | 3.55 | 2.94 | 2.77 | 2.36 | 0.98 | 1.42 | 1.06 | 1.82 | 1.63 | 0.90 | 0.02 | -0.22 | 0.82 | 0.32 | 2.81 | 2.53 | 2.05 | 1.83 | 1.66 | 1.45 | 1.20 | 1.11 | 0.88 | 0.73 |
| Diluted Shares Outstanding | 1.67B | 1.71B | 1.78B | 1.84B | 1.91B | 1.95B | 1.94B | 1.96B | 1.99B | 1.99B | 1.98B | 1.98B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B |
Quick answers to the most common questions about buying MFC stock.
For fiscal year 2025, Manulife Financial Corporation (MFC) reported total revenue of $53.01B. This represents a 403.5% increase compared to $10.53B in 1998.
Manulife Financial Corporation (MFC) is profitable, generating $5.78B in net income for the fiscal year ending 2025 with a net profit margin of 10.9%.
Manulife Financial Corporation (MFC) reported an operating income of $7.09B, resulting in an operating profit margin of 13.4%. This margin reflects the operational efficiency of the business before interest and taxes.
Manulife Financial Corporation (MFC) generated $13.53B in gross profit for the year, representing a gross profit margin of 25.5%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
WAM outflows and regulatory scrutiny
Premium Growth Distorted by IFRS 17
Reported revenue swings wildly, with 827% YoY growth in 2025Q2, but this appears to be an artifact of IFRS 17 transition rather than organic expansion, as per regulatory filings.
The revenue trajectory is highly volatile, with quarterly figures ranging from $4.2B to $41.1B, reflecting the new accounting standard's reclassification of investment and reinsurance components. Excluding the transition noise, underlying premium growth in Asia likely remains positive, supported by the reopening of the Hong Kong-Mainland China border, but the WAM segment's persistent net outflows suggest a drag on fee-based revenue. Investors should focus on CSM growth as a more reliable indicator of new business momentum.
Underwriting Profitability Holds Steady
Combined ratios have improved to 85.9% in 2026Q2 from 96.4% in 2024Q1, indicating stronger underwriting discipline, though loss ratios remain volatile due to IFRS 17 adjustments.
The combined ratio has generally trended below 100%, with the latest quarter at 85.9%, suggesting solid underwriting profitability. However, the loss ratio swings dramatically (from -84.3% to 92.1%) due to accounting reclassifications, making period-over-period comparisons unreliable. The underlying improvement likely stems from disciplined pricing and a shift toward capital-light products, but the sustainability of these margins depends on claims experience in the LTC block and healthcare cost inflation.
Reserve Releases Mask Underlying Trends
Prior-year reserve releases appear to have boosted earnings, as evidenced by negative loss ratios in 2024Q3, but this may not reflect ongoing operational performance, according to financial statements.
The negative loss ratio of -84.3% in 2024Q3 indicates significant favorable reserve development, which inflated net income. While this suggests that prior reserves were redundant, it also raises questions about the quality of current earnings. If such releases are one-time in nature, future profitability could be lower than recent quarters imply. Investors should monitor experience gains/losses to assess whether reserve adequacy is improving or deteriorating.
Investment Income Supports Earnings
Investment income is not separately disclosed, but net income of $2.2B in 2026Q2 suggests strong contribution from the general account, given the low combined ratio, as per reported figures.
With a combined ratio of 85.9%, underwriting alone is profitable, but investment income remains a critical component of total earnings, especially for life insurance products with long-duration liabilities. In a rising rate environment, reinvestment yields likely improve, enhancing the spread between investment returns and policyholder crediting rates. However, the lack of explicit investment income data limits a full assessment of yield trends and asset-liability management.
Expense Ratio Reflects Scale Benefits
The expense ratio, implied by the combined ratio, appears efficient at around 8-10%, benefiting from scale in Asia and the U.S., though WAM outflows may pressure fee-based margins.
The expense ratio, derived from the combined ratio and loss ratio, is relatively low, indicating operational efficiency. Manulife's dual-hemisphere distribution and integrated asset management likely provide cost advantages. However, the persistent net outflows in the WAM segment could lead to higher expense ratios if assets under management decline, as fixed costs are spread over a smaller base. Monitoring the expense ratio in upcoming quarters will be key to assessing the impact of these outflows.
Earnings Quality Questioned by Accounting Noise
The 827% revenue growth and volatile loss ratios are likely artifacts of IFRS 17, raising concerns about the reliability of reported earnings, as disclosed in financial statements.
The transition to IFRS 17 has made headline revenue and loss ratios nearly meaningless for trend analysis. The reported figures may not reflect the true economic performance of the business, and investors could be misled by the apparent profitability. Additionally, the persistent WAM outflows and regulatory scrutiny in Hong Kong could pressure future earnings, suggesting that the current stability may be fragile. A thorough analysis of CSM and core earnings is necessary to gauge the underlying health of the company.